We are live on ! Find out more
RXII

GALENA BIOPHARMA INC COM
RXII

Delisted

RXII was delisted on the 25th of October, 2011.

Back to rankings

0 hedge funds and large institutions have $0 invested in GALENA BIOPHARMA INC COM in 2016 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 90 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 91 → 0 (-91)

100% less capital invested

Capital invested by funds: $11.5M → $0 (-$11.5M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 90

Holders
–
Holders Change
-91
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
90
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$2.93M
2
BFA
BlackRock Fund Advisors
California
-$2.11M
3
BIT
BlackRock Institutional Trust
California
-$1.54M
4
State Street
State Street
Massachusetts
-$1.01M
5
Northern Trust
Northern Trust
Illinois
-$715K
Name Holding Trade Value Shares
Change 		Change in
Stake
Legal & General Group
51
Legal & General Group
United Kingdom
– -$8K -23,219 Closed
Millennium Management
52
Millennium Management
New York
– -$8K -22,500 Closed
ProShare Advisors
53
ProShare Advisors
Maryland
– -$7K -20,894 Closed
CG
54
Cutler Group
California
– -$7K -20,014 Closed
AB
55
Amalgamated Bank
New York
– -$7K -19,454 Closed
Simplex Trading
56
Simplex Trading
Illinois
– -$6K -18,771 Closed
Prudential Financial
57
Prudential Financial
New Jersey
– -$6K -16,680 Closed
Bank of Montreal
58
Bank of Montreal
Ontario, Canada
– -$5K -15,930 Closed
AG
59
Advisor Group
Arizona
– -$5K -15,262 Closed
Creative Planning
60
Creative Planning
Kansas
– -$5K -15,100 Closed
AIM
61
Aspen Investment Management
Michigan
– -$5K -15,000 Closed
CWM
62
Concert Wealth Management
California
– -$5K -14,961 Closed
AIP
63
Ameritas Investment Partners
Nebraska
– -$5K -14,289 Closed
BNP Paribas Financial Markets
64
BNP Paribas Financial Markets
France
– -$4.64K -13,266 Closed
BlackRock
65
BlackRock
New York
– -$4K -12,812 Closed
N
66
Nuveen
North Carolina
– -$4K -12,136 Closed
LPL Financial
67
LPL Financial
California
– -$4K -11,674 Closed
Comerica Bank
68
Comerica Bank
Texas
– -$4K -11,500 Closed
Fisher Asset Management
69
Fisher Asset Management
Washington
– -$4K -11,329 Closed
ID
70
Integral Derivatives
New York
– -$4K -10,901 Closed
CA
71
Commerzbank Aktiengesellschaft
Germany
– -$4K -10,658 Closed
BCM
72
Buckhead Capital Management
Georgia
– -$4K -10,640 Closed
RJA
73
Raymond James & Associates
Florida
– -$4K -10,500 Closed
D.E. Shaw & Co
74
D.E. Shaw & Co
New York
– -$4K -10,097 Closed
Bank of America
75
Bank of America
North Carolina
– -$4K -9,839 Closed
1 2
3
4

RXII Hedge Fund Activity: Q4 2016 in Review

0 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in GALENA BIOPHARMA INC COM (RXII) for Q4 2016, worth a combined $0 — down 100% from $11.5M a quarter earlier.

Sellers outnumbered buyers: 90 funds closed out of RXII and 0 opened new positions — a net loss of 90 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $2.93M sold.

  • 0 institutional investors held GALENA BIOPHARMA INC COM (RXII) as of Q4 2016, down from 91 in Q3 2016.
  • Funds reported $0 of GALENA BIOPHARMA INC COM stock for Q4 2016, down 100% quarter-over-quarter.
  • 0 funds opened new GALENA BIOPHARMA INC COM positions in Q4 2016 and 90 closed out, a net change of -90 holders.
  • The largest GALENA BIOPHARMA INC COM seller in Q4 2016 was Vanguard Group, an estimated $2.93M sold.

Based on aggregated 13F filings for Q4 2016.